ArticleNeurocritical care2026
Hematoma Coagulation is Associated with Perihematoma Edema Volume in Patients with Acute Intracerebral Hemorrhage.
Article in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn acute intracerebral hemorrhage (ICH), hematoma mass and perihematomal edema (PHE) contribute to elevated intracranial pressure (ICP). The release of red blood cell lysis products accelerates PHE formation. Animal studies show that the accumulation of blood-clotting factors contributes to PHE growth. Controlling hematoma expansion (HE) remains a medical priority. Promoting hematoma coagulation reduces HE; however, coagulation may increase PHE. Using quantitative magnetic resonance imaging (MRI) for imaging coagulation status, we studied the interaction between coagulation and PHE.
methodsTwenty patients with hypertensive ICH who completed three consecutive MRIs at three time points (T1, T2, T3) within the first 72 h after onset were included in this study. Images were obtained on a 3 T MRI system with three-dimensional (3D) FLAIR, T1w, and multi-gradient echo (mGRE) sequences. FLAIR and mGRE images quantified the hematoma volume (HV) and PHE volume, while clotted blood volume (CBVol) was measured via Quantitative Susceptibility Maps (QSM). Within the hematoma, voxels with susceptibility greater than 0.5 ppm were considered clotted blood. CBVol was analyzed in relation to hematoma and PHE volumes. Group-wise comparisons across serial time points were performed using Wilcoxon signed-rank tests.
resultsAmong 12 M/8F patients, the mean age was 63.4 ± 11.5 years. Between the first (T1) and last imaging (T3), the PHE volume (22.6 ± 14.2 to 31.5 ± 20.2 mL; p = 0.005), and CBVol (3.21 ± 3.3 to 5.58 ± 4.8 mL; p = 0.0007) significantly increased. The CBVol demonstrated a significant positive correlation with PHE volume at T2 (r = 0.543, p < 0.05) and T3 (r = 0.80, p < 0.001). After adjusting for HV, the association remained independently significant at T3 [(partial r = 0.554, p = 0.021)]. Similarly, HV showed a strongly significant association with PHE volume at all time points (p < 0.001), and after adjusting for CBVol, the association remained significant across all time points [(partial r = 0.578-0.692, all p < 0.02)].
conclusionsBoth hematoma clotting and hematoma size influence PHE volume. The findings of this study have implications for clinical management when treating patients with procoagulant therapies.
Indexed as
Identifiers
42487083What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.